Back to Search
Start Over
More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules.
- Source :
-
Nature structural & molecular biology [Nat Struct Mol Biol] 2014 Mar; Vol. 21 (3), pp. 282-288. Date of Electronic Publication: 2014 Feb 09. - Publication Year :
- 2014
-
Abstract
- Enterovirus 71 (HEV71) epidemics in children and infants result mainly in mild symptoms; however, especially in the Asia-Pacific region, infection can be fatal. At present, no therapies are available. We have used structural analysis of the complete virus to guide the design of HEV71 inhibitors. Analysis of complexes with four 3-(4-pyridyl)-2-imidazolidinone derivatives with varying anti-HEV71 activities pinpointed key structure-activity correlates. We then identified additional potentially beneficial substitutions, developed methods to reliably triage compounds by quantum mechanics-enhanced ligand docking and synthesized two candidates. Structural analysis and in vitro assays confirmed the predicted binding modes and their ability to block viral infection. One ligand (with IC50 of 25 pM) is an order of magnitude more potent than the best previously reported inhibitor and is also more soluble. Our approach may be useful in the design of effective drugs for enterovirus infections.
- Subjects :
- Antiviral Agents chemistry
Binding Sites
Chemistry, Pharmaceutical
Drug Design
Enterovirus Infections drug therapy
Enterovirus Infections virology
Inhibitory Concentration 50
Ligands
Protein Binding
Protein Conformation
Structure-Activity Relationship
Capsid chemistry
Capsid Proteins chemistry
Enterovirus A, Human drug effects
Imidazoles chemistry
Subjects
Details
- Language :
- English
- ISSN :
- 1545-9985
- Volume :
- 21
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Nature structural & molecular biology
- Publication Type :
- Academic Journal
- Accession number :
- 24509833
- Full Text :
- https://doi.org/10.1038/nsmb.2769